Mark Cuban Says Were He To Become President For A Day, He Would Make These Two Simple Moves To Overhaul US Healthcare

Billionaire entrepreneur and Cost Plus Drugs founder Mark Cuban believes that these two changes could dramatically improve the U.S. healthcare system.

What Happened: On Thursday, Cuban responded to a question about what two changes he would make to fix the U.S. healthcare system, if he had full power for one day as president.

Instead of just giving two, he outlined several bold policy ideas targeting one major issue: prescription drug pricing and healthcare payment systems.

He proposed separating formularies from pharmacy benefit managers (PBMs) and any companies they own. "They removed their leverage," Cuban said, implying that PBMs have too much control over pricing and access.

Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become an investor for $0.80 per share.

The billionaire also suggested a rule that would force Medicare Advantage and Part D plans to buy from any provider offering a lower price than what patients currently pay out of pocket.

Beyond those two ideas, Cuban added more potential reforms: requiring providers to honor publicly listed cash prices, banning specialty drug pricing tiers and making provider CEOs personally liable in cases of billing fraud.

“Put together a financing plan for all healthcare out-of-pocket costs, held by the provider, guaranteed by the Feds. And personally guaranteed against fraud by provider CEOs (to end provider fraud),” he said.

See Also: Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can invest with $1,000 at just $0.30/share.

Why It's Important: Cuban’s Cost Plus Drug Company, launched in 2022, has quickly grown by offering transparent pricing and cutting out middlemen to lower prescription drug costs.

Its Cost Plus Marketplace, introduced in February 2024, started with over 4,000 medicines—mainly those in short supply—and has since expanded to over 6,000, supporting healthcare providers nationwide.

Earlier, Elon Musk criticized the high cost of U.S. healthcare, questioning the lack of value for the money spent. In response, Cuban responded by blaming not just the government but also CEOs of self-insured companies for signing contracts with PBMs that drive up drug prices.

Photo Courtesy: Kathy Hutchins on Shutterstock.com

Read Next:

• Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential.
• Bezos' Favorite Real Estate Platform Launches A Way To Ride The Ongoing Private Credit Boom